E
E. C. Squiers
Researcher at State University of New York System
Publications - 12
Citations - 501
E. C. Squiers is an academic researcher from State University of New York System. The author has contributed to research in topics: Transplantation & Isograft. The author has an hindex of 7, co-authored 12 publications receiving 473 citations.
Papers
More filters
Journal ArticleDOI
Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation
Osama Gaber,M. Roy First,Raymond J. Tesi,Robert S. Gaston,Robert Mendez,Laura L. Mulloy,Jimmy A. Light,Lillian W. Gaber,E. C. Squiers,Rodney J. Taylor,John F. Neylan,Robert W. Steiner,Stuart J. Knechtle,Douglas J. Norman,Fuad S. Shihab,Giacomo Basadonna,Daniel C. Brennan,Ernest E. Hodge,Barry D. Kahan,Lawrence Kahana,Steven M. Steinberg,E. Steve Woodle,Laurence Chan,John M. Ham,Robert J. Stratta,Erik Wahlstrom,Kathleen R. Lamborn,H. Rossiter Horn,Hana Berger Moran,Philippe Pouletty,Timothy J. Schroeder +30 more
TL;DR: Thymoglobulin was found to be superior to Atgam in reversing acute rejection and preventing recurrent rejection after therapy in renal transplant recipients.
Journal ArticleDOI
rPSGL‐Ig for Improvement of Early Liver Allograft Function: A Double‐Blind, Placebo‐Controlled, Single‐Center Phase II Study†
Ronald W. Busuttil,Gerald S. Lipshutz,Jerzy W. Kupiec-Weglinski,S. Ponthieux,David W. Gjertson,Christopher Cheadle,Tonya Watkins,Eva Ehrlich,Eliezer Katz,E. C. Squiers,Hamid Rabb,Stefan Hemmerich +11 more
TL;DR: This is the first clinical trial of an adhesion molecule antagonist to demonstrate a beneficial effect on liver transplantation IRI and supported by therapeutic modulation of two hepatic IRI biomarkers.
Journal ArticleDOI
Large granular lymphocyte leukaemia occurring after renal transplantation
Teresa C. Gentile,Kennethe G. Hadlock,Aysegul Hasegeli Uner,Buck Delal,E. C. Squiers,Suzanne Crowley,Richard C. Woodman,Steven K. H. Foung,Bernard J. Poiesz,Thomas P. Loughran +9 more
TL;DR: Data show that LGL leukaemia should be included as one of the types of T‐cell proliferations which can occur post transplant, and that EBV does not appear to be involved in pathogenesis.
Journal ArticleDOI
YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study
A. Osama Gaber,Shamkant Mulgaonkar,Barry D. Kahan,E. Steve Woodle,Rita R. Alloway,I Bajjoka,Stephen C. Jensik,Goran B. Klintmalm,Pamela R. Patton,Alexander C. Wiseman,Gerald S. Lipshutz,Jerzy W. Kupiec-Weglinski,Lilian W. Gaber,Eliezer Katz,William Irish,E. C. Squiers,Stefan Hemmerich +16 more
TL;DR: YSPSL (rPSGL‐Ig) for improvement of early renal allograft function: A double‐blind, placebo‐controlled, multi‐center Phase IIa study.